The burgeoning landscape of innovative treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a alike https://victorwyul043132.wikifrontier.com/8649285/retatrutide_vs_tirzepatide_a_comparative_analysis